News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Jubilant HollisterStier plans $70 million expansion
Jubilant HollisterStier, a pharmaceutical manufacturing company based in Spokane, announced its plan to double existing space and manufacturing capacity and add 400 employees over the

Microsoft rolls out COVID-19 vaccine management platform as nationwide distribution gets underway
Microsoft has launched a vaccine management platform for both government and healthcare customers as the COVID-19 vaccine begins its nationwide rollout. The solutions will enable

Biotech of the Year: Seagen
Seagen, formerly Seattle Genetics, was named BioPharmaDive’s 2020 Biotech of the Year. Per BioPharma Dive: “Once a tiny, cash-strapped startup…Seagen is the largest biotech in

Lundbeck taps Mental Health America—and its big data—to create a national crisis dashboard
Lundbeck, which has operations in Bothell, Washington, will back a new nationwide mental health dashboard from Mental Health America that aims to track mental health

Athira Pharma wins $15M grant from National Institute on Aging for trial of Alzheimer’s drug
Seattle-based Athira Pharma announced that it received a three-year grant totaling $15 million from the National Institute on Aging. The funding will support an upcoming clinical

WSU Spokane launches life sciences startup incubator
Washington State University in Spokane announced the opening of Spinout Space, or Sp3nw, a life sciences incubator for launching startups. The goal of Sp3nw is

Silverback hits Wall Street with chest-thumping $242M IPO
Seattle-based Silverback Therapeutics more than doubled its original IPO hopes with a $242 million debut on the Nasdaq Stock Market. Originally shooting for a $100

How culture and leadership helped ventilator maker Ventec meet huge demand in COVID-19 response
Bothell-based Ventec Life Systems, one of the few ventilator manufacturers in the U.S., pulled off a massive feat earlier this year when it partnered with

Seattle biotech firm Umoja Biopharma raises $53M as it tackles unique approach to immunotherapy
Umoja Biopharma, a startup founded last year by Seattle biotech veteran Andy Scharenberg, announced that it has raised $53 million in a recent Series A

Seattle Children’s Therapeutics leverages biotech innovation in quest for new treatments for kids
Seattle Children’s Hospital, consistently ranked as one of the best children’s hospitals in the U.S., has launched a new endeavor: Seattle Children’s Therapeutics. This research institution

BMS earmarks $100M of its $300M equity pledge for diverse clinical trial investigators
Following its August 2020 pledge to allocate $300 million over the next five years to diversity initiatives, Bristol Myers Squibb announced that $100 million of that

New Type of Test May Better Discern Immunity to the Coronavirus
Seattle-based Adaptive Biotechnologies has developed a new type of COVID-19 test that uses a blood sample to determine immune response to the virus. The test
